Home/Filings/4/0001209191-21-016882
4//SEC Filing

Andreano Dominic J 4

Accession 0001209191-21-016882

CIK 0000893949other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:36 PM ET

Size

7.5 KB

Accession

0001209191-21-016882

Insider Transaction Report

Form 4
Period: 2021-03-01
Andreano Dominic J
Sr.VP,General Counsel & Secy.
Transactions
  • Award

    Common Stock

    2021-03-01+27,551102,945 total
  • Award

    Common Stock

    2021-03-01+27,552130,497 total
Footnotes (2)
  • [F1]Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 13,776 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2021. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three installments of twenty-five percent (25%) on March 1, 2022, twenty-five percent (25%) on March 1, 2023 and fifty percent (50%) on March 1, 2024, subject to the terms of the Plan.
  • [F2]Restricted shares granted pursuant to the Issuer's Plan, in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2022, twenty-five percent (25%) of the restricted shares will vest on March 1, 2023 and fifty percent (50%) of the restricted shares will vest on March 1, 2024, subject to the terms of the Plan.

Issuer

MEDNAX, INC.

CIK 0000893949

Entity typeother

Related Parties

1
  • filerCIK 0001549694

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:36 PM ET
Size
7.5 KB